Key result
Early catheter ablation linked to lower 2-year mortality and HF readmission across age and EF strata.
Why the study?
The prognostic impact of catheter ablation performed early after hospitalization for acute HF with AF remained uncertain, particularly among elderly patients and those with preserved ejection fraction who are underrepresented in randomized trials.
Does early catheter ablation within 3 months after discharge reduce the composite of all-cause mortality and heart failure readmission at 2 years compared to optimal medical therapy alone in patients hospitalized for acute heart failure with atrial fibrillation?
Cohort (n=400)
No
Does early catheter ablation within 3 months after discharge reduce the composite of all-cause mortality and heart failure readmission at 2 years compared to optimal medical therapy alone in patients hospitalized for acute heart failure with atrial fibrillation?
Early catheter ablation within 3 months of hospitalization for acute heart failure and atrial fibrillation is associated with lower 2-year mortality and heart failure readmission rates across both elderly and non-elderly patients and regardless of ejection fraction.
Answers are grounded in this paper and cite their sources.
May support early ablation post-acute HF with AF; hypothesis-generating across strata, pending randomized confirmation.
Background Atrial fibrillation (AF) frequently complicates acute decompensated heart failure (HF) and is associated with increased mortality and recurrent hospitalization. Although catheter ablation (CA) has demonstrated prognostic benefit in selected HF populations, its impact when performed early after hospitalization for acute HF remains uncertain, particularly in elderly patients and those with preserved ejection fraction (EF), who are underrepresented in randomized trials. We aimed to evaluate the prognostic impact of early CA across age and EF strata in a real-world cohort of patients hospitalized with acute HF and AF. Methods We retrospectively analyzed 400 consecutive patients admitted for acute HF with AF between 2019 and 2022 at a tertiary cardiovascular center. Patients were stratified according to treatment strategy: those who underwent CA within 3 months after discharge (CA group) and those managed with optimal medical therapy alone (OMT group). The primary endpoint was a composite of all-cause mortality and HF readmission at 2 years. Outcomes were assessed using Kaplan–Meier analysis and Cox proportional hazards models. To minimize selection bias, propensity score matching was performed, yielding 54 well-balanced pairs. Prespecified subgroup analyses were conducted according to age (≥75 vs. <75 years) and EF (<40% vs. ≥40%). Results During 2-year follow-up, crude analyses demonstrated that the CA group had significantly lower all-cause mortality compared with the OMT group (Figure A). Crude HF readmission rates were also significantly reduced in patients who underwent early CA (Figure B). In crude analyses of the composite endpoint, early CA was associated with significant risk reduction across age categories, with consistent benefit observed in both patients aged ≥75 years and those <75 years (Figure C). Similarly, EF-stratified crude analyses showed that CA significantly reduced the composite endpoint in both patients with reduced EF (<40%) and those with EF ≥40% (Figure D). After propensity score matching, these findings remained consistent. In the matched cohort, early CA continued to show significant reduction in the composite endpoint across both age strata (Figure E). Likewise, EF-based analyses after matching confirmed that CA conferred significant prognostic benefit irrespective of systolic function (Figure F). Conclusion Early catheter ablation within 3 months following hospitalization for acute HF was associated with significant reduction in 2-year mortality and HF readmission. The prognostic benefit was consistently observed across elderly and non-elderly patients as well as across reduced and preserved EF. These findings support early rhythm control with CA as a potentially effective strategy in a broad spectrum of patients with acute HF and AF.
No takes yet. Share an insight, caveat, or question.
Okahara et al. (2026) conducted a cohort in Acute heart failure with atrial fibrillation (n=400). Early catheter ablation (within 3 months after discharge) vs. Optimal medical therapy alone (OMT) was evaluated on Composite of all-cause mortality and heart failure readmission at 2 years. Early catheter ablation within 3 months of acute HF discharge significantly reduced 2-year mortality and HF readmission compared with optimal medical therapy across age (≥75 vs <75) and EF strata.
Synapse has enriched 10 related papers. Consider them for comparative context: